Symptomatic joint hypermobility

Key points

1. 01Generalized joint hypermobility (GJH) is quickly assessed in clinic using the Beighton scoring system (maximum score 9), with no special equipment required
2. 02Symptomatic GJH can present as soft-tissue pain, chronic diffuse pain, joint instability, fatigue, postural dizziness (including POTS), and functional GI disorders
3. 03GJH may be a feature of heritable connective tissue disorders such as hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD) - genetic testing confirms most EDS types but hEDS and HSD are diagnosed clinically only
4. 04Physical and occupational therapy are the mainstay of management, using low-resistance exercises, neuromuscular re-education, orthotics, and ergonomics instruction
5. 05Joint hypermobility is a sex-influenced trait: females commonly become symptomatic in the years after puberty while males tend to show decreasing joint mobility

How it was conducted

Design

Narrative clinical review

Scope

Symptomatic joint hypermobility including hEDS and HSD; excludes other named syndromes except where overlap exists

Assessment tool discussed

Beighton scoring system (9 points) and the 5-point self-report questionnaire

Management discussed

Physical/occupational therapy, bracing, orthotics, pharmacological options for orthostasis, dietary approaches for GI symptoms

Author affiliation

Division of Medical Genetics, Peyton Manning Children's Hospital, Indianapolis, IN, USA

What they found

• The 5-point hypermobility questionnaire has 85% sensitivity and 90% specificity for detecting joint hypermobility when two or more questions are answered positively (Grahame and Hakim, 2003)
• The Beighton scoring system has a total possible score of 9; a recent comprehensive review found it to be the most reproducible tool with good inter-rater reliability
• Knee hypermobility is typically accompanied by quadriceps weakness and hamstring tightness, both of which can be addressed through targeted exercise to reduce pain

Limitations

• Narrative review design with no systematic search strategy or quality appraisal of included studies
• The author explicitly states that high-quality, objective, evidence-based interventional trials in GJH are scarce, limiting clinical guidance
• Many quantitative values in the source text (prevalence estimates, Beighton cutoff thresholds, specific degree measurements) could not be confirmed from the extracted text
• Management recommendations are largely expert opinion and consensus rather than derived from controlled trials

Why it matters

For patients

People with chronic joint pain, fatigue, or recurrent dislocations should ask their clinician about a Beighton score assessment, as recognising hypermobility can direct them toward effective physical therapy rather than unnecessary investigations.

For clinicians

Screening for GJH with the Beighton system in patients with musculoskeletal complaints can uncover a systemic connective tissue disorder and guide targeted neuromuscular rehabilitation, reducing the burden of misdiagnosis.

For readers

This review maps the full clinical picture of symptomatic joint hypermobility - from assessment tools and classification (hEDS vs HSD) to multi-system comorbidities and treatment principles - providing a practical clinical reference.